Use of Pulmonary Hypertension Medications in Patients with Tetralogy of Fallot with Pulmonary Atresia and Multiple Aortopulmonary Collaterals View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2016-02

AUTHORS

Elena K. Grant, John T. Berger

ABSTRACT

Tetralogy of Fallot (TOF) with pulmonary atresia (PA) and multiple aortopulmonary collaterals (MAPCAs) is a rare and severe form of congenital heart disease with poor prognosis. Aortopulmonary collaterals expose pulmonary arterioles to systemic pressure resulting in pulmonary hypertension (PH). To date, reports regarding the role of PH medications in this population are sparse. The objective of this study was to assess the effect of PH medications in patients with TOF, PA and MAPCAs or similar anatomy, with emphasis on symptoms, echocardiography and invasive hemodynamics. A retrospective review was performed for patients at a single tertiary care pediatric center. Twelve of 66 patients were treated with PH medications (18 %), and eight of these patients had adequate follow-up for further analysis. Median age at last follow-up was 6 years (range 1.4-21 years). Median length of therapy with PH medication was 4 years (range 0.3-17 years). PH medications included sildenafil, bosentan, ambrisentan, inhaled treprostinil and prostacyclin infusion. PH therapy was associated with improvement in symptoms in all patients and improvement in PH by hemodynamic measures in the majority of patients. All patients underwent at least one cardiac intervention by catheterization or surgery while taking PH medication. Two patients died from non-PH-related causes. The remaining six patients are alive and remain on PH medication. This review indicates that PH medications are well tolerated by this patient group and provide symptomatic improvement. Further studies are required to determine whether PH medications provide long-term survival benefit for patients with complex congenital heart disease. More... »

PAGES

304-312

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00246-015-1278-2

DOI

http://dx.doi.org/10.1007/s00246-015-1278-2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1027960295

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/26511384


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Abnormalities, Multiple", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antihypertensive Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Catheterization", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child, Preschool", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "District of Columbia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Echocardiography", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hemodynamics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hospitals, Pediatric", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypertension, Pulmonary", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infant, Newborn", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lung", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phenylpropionates", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pulmonary Artery", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pulmonary Atresia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pyridazines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sildenafil Citrate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sulfonamides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tertiary Care Centers", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tetralogy of Fallot", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Children\u2019s National Health System", 
          "id": "https://www.grid.ac/institutes/grid.239560.b", 
          "name": [
            "Division of Cardiology, Children\u2019s National Health System, 111 Michigan Avenue NW, 20010, Washington, DC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Grant", 
        "givenName": "Elena K.", 
        "id": "sg:person.01167214005.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01167214005.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Children\u2019s National Health System", 
          "id": "https://www.grid.ac/institutes/grid.239560.b", 
          "name": [
            "Division of Cardiology, Children\u2019s National Health System, 111 Michigan Avenue NW, 20010, Washington, DC, USA", 
            "Division of Critical Care Medicine, Children\u2019s National Health System, 111 Michigan Avenue NW, 20010, Washington, DC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Berger", 
        "givenName": "John T.", 
        "id": "sg:person.01335364706.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01335364706.04"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.ijcard.2007.08.016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011119728"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/j.pcsu.2009.01.017", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011551210"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0735-1097(94)00364-v", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017446456"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circulationaha.109.192230", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018087707"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00246-012-0598-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026109233", 
          "https://doi.org/10.1007/s00246-012-0598-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circulationaha.113.005698", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028705550"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circulationaha.113.005698", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028705550"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/pep.0b013e3182095e44", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038928599"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/pep.0b013e3182095e44", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038928599"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijcard.2012.03.021", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044464960"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijcard.2011.06.084", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046960818"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-02", 
    "datePublishedReg": "2016-02-01", 
    "description": "Tetralogy of Fallot (TOF) with pulmonary atresia (PA) and multiple aortopulmonary collaterals (MAPCAs) is a rare and severe form of congenital heart disease with poor prognosis. Aortopulmonary collaterals expose pulmonary arterioles to systemic pressure resulting in pulmonary hypertension (PH). To date, reports regarding the role of PH medications in this population are sparse. The objective of this study was to assess the effect of PH medications in patients with TOF, PA and MAPCAs or similar anatomy, with emphasis on symptoms, echocardiography and invasive hemodynamics. A retrospective review was performed for patients at a single tertiary care pediatric center. Twelve of 66 patients were treated with PH medications (18 %), and eight of these patients had adequate follow-up for further analysis. Median age at last follow-up was 6 years (range 1.4-21 years). Median length of therapy with PH medication was 4 years (range 0.3-17 years). PH medications included sildenafil, bosentan, ambrisentan, inhaled treprostinil and prostacyclin infusion. PH therapy was associated with improvement in symptoms in all patients and improvement in PH by hemodynamic measures in the majority of patients. All patients underwent at least one cardiac intervention by catheterization or surgery while taking PH medication. Two patients died from non-PH-related causes. The remaining six patients are alive and remain on PH medication. This review indicates that PH medications are well tolerated by this patient group and provide symptomatic improvement. Further studies are required to determine whether PH medications provide long-term survival benefit for patients with complex congenital heart disease.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00246-015-1278-2", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1091102", 
        "issn": [
          "0172-0643", 
          "1432-1971"
        ], 
        "name": "Pediatric Cardiology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "37"
      }
    ], 
    "name": "Use of Pulmonary Hypertension Medications in Patients with Tetralogy of Fallot with Pulmonary Atresia and Multiple Aortopulmonary Collaterals", 
    "pagination": "304-312", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "85316f006f2d53ad1f55b2544717a34d2bf0f08923d6eec1ae960235933634c3"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "26511384"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8003849"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00246-015-1278-2"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1027960295"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00246-015-1278-2", 
      "https://app.dimensions.ai/details/publication/pub.1027960295"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T15:01", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8663_00000513.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs00246-015-1278-2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00246-015-1278-2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00246-015-1278-2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00246-015-1278-2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00246-015-1278-2'


 

This table displays all metadata directly associated to this object as RDF triples.

213 TRIPLES      21 PREDICATES      65 URIs      48 LITERALS      36 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00246-015-1278-2 schema:about N2cf790a2ed514a958cc14e3689287537
2 N44b0cb20ff0e492094cadb7200760d07
3 N57525419efaa4316b780cca453375e97
4 N5bfd2da748ea4479b57dba2f9180310e
5 N5d9cd0fc6c174028b900dc6a5e073cd3
6 N669d5b9fa12f42e0bb1ae270aad871f4
7 N7bedbeb554e1443eacc0c7fcfb0fe6ae
8 N8a83458c03f84c5a86dcfb89f0de8371
9 N9856b9778a494e23a083aee0a2f55985
10 Na15ef977ac114eb78763da722d1f59d6
11 Na2bf8183f35743878e3d3034a831e88b
12 Nb4ddeeda409f4e86b1b73b0bd638aaed
13 Nb50c60af0c2f4e048e70ac8a4098e679
14 Nc197be0ec5bb4206bfe824c69df1eb03
15 Nca2bbb5a9ca541bda1f4dbc397eca934
16 Nce8edd46ce50471388baf69697be4d29
17 Ncf26dba57694496ab44f4e97cb7df878
18 Nd559256b923c46b7b8d9c60797d564d5
19 Ne1a709498fa549f09a0ed4d3712f499b
20 Ne1ad277e0e6745eaa411d6e511a8b677
21 Ne5738c23e7054330b4beb87a5862b240
22 Ne77cc82e93144ab7a56f787bafff5f31
23 Ne7e32e71d32047bfaf04cdd9899a6c1f
24 Ne925e005ab0445d8955b6eb8b9936686
25 Neab702f8978746fbbe907558ca1bf130
26 Nf75c0ce15e574d6aa24b9611d32227ae
27 Nf8f1e2749ff8402d9285317c18ad812a
28 anzsrc-for:11
29 anzsrc-for:1102
30 schema:author N5a4c5af2ebac42818f0c9e0257c642e3
31 schema:citation sg:pub.10.1007/s00246-012-0598-8
32 https://doi.org/10.1016/0735-1097(94)00364-v
33 https://doi.org/10.1016/j.ijcard.2007.08.016
34 https://doi.org/10.1016/j.ijcard.2011.06.084
35 https://doi.org/10.1016/j.ijcard.2012.03.021
36 https://doi.org/10.1053/j.pcsu.2009.01.017
37 https://doi.org/10.1097/pep.0b013e3182095e44
38 https://doi.org/10.1161/circulationaha.109.192230
39 https://doi.org/10.1161/circulationaha.113.005698
40 schema:datePublished 2016-02
41 schema:datePublishedReg 2016-02-01
42 schema:description Tetralogy of Fallot (TOF) with pulmonary atresia (PA) and multiple aortopulmonary collaterals (MAPCAs) is a rare and severe form of congenital heart disease with poor prognosis. Aortopulmonary collaterals expose pulmonary arterioles to systemic pressure resulting in pulmonary hypertension (PH). To date, reports regarding the role of PH medications in this population are sparse. The objective of this study was to assess the effect of PH medications in patients with TOF, PA and MAPCAs or similar anatomy, with emphasis on symptoms, echocardiography and invasive hemodynamics. A retrospective review was performed for patients at a single tertiary care pediatric center. Twelve of 66 patients were treated with PH medications (18 %), and eight of these patients had adequate follow-up for further analysis. Median age at last follow-up was 6 years (range 1.4-21 years). Median length of therapy with PH medication was 4 years (range 0.3-17 years). PH medications included sildenafil, bosentan, ambrisentan, inhaled treprostinil and prostacyclin infusion. PH therapy was associated with improvement in symptoms in all patients and improvement in PH by hemodynamic measures in the majority of patients. All patients underwent at least one cardiac intervention by catheterization or surgery while taking PH medication. Two patients died from non-PH-related causes. The remaining six patients are alive and remain on PH medication. This review indicates that PH medications are well tolerated by this patient group and provide symptomatic improvement. Further studies are required to determine whether PH medications provide long-term survival benefit for patients with complex congenital heart disease.
43 schema:genre research_article
44 schema:inLanguage en
45 schema:isAccessibleForFree false
46 schema:isPartOf N230abbaca3e745b290b8d4c25a9ee121
47 N428ca519240b42948daf32128d698c5d
48 sg:journal.1091102
49 schema:name Use of Pulmonary Hypertension Medications in Patients with Tetralogy of Fallot with Pulmonary Atresia and Multiple Aortopulmonary Collaterals
50 schema:pagination 304-312
51 schema:productId N3b447edcac5f45f0b4dc6519bb650147
52 N4adb1a9ab147480a9641f068d1e8f2c9
53 Nd09cddcbc8304a498eb35bd3a81435c4
54 Nf414871eb01141c6ac5b312feb6237e2
55 Nfd7f9318de0d4d56962d79e63bd7f49b
56 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027960295
57 https://doi.org/10.1007/s00246-015-1278-2
58 schema:sdDatePublished 2019-04-10T15:01
59 schema:sdLicense https://scigraph.springernature.com/explorer/license/
60 schema:sdPublisher Nd91043e806c94e2082a812b45690e09d
61 schema:url http://link.springer.com/10.1007%2Fs00246-015-1278-2
62 sgo:license sg:explorer/license/
63 sgo:sdDataset articles
64 rdf:type schema:ScholarlyArticle
65 N230abbaca3e745b290b8d4c25a9ee121 schema:volumeNumber 37
66 rdf:type schema:PublicationVolume
67 N2cf790a2ed514a958cc14e3689287537 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
68 schema:name Tetralogy of Fallot
69 rdf:type schema:DefinedTerm
70 N3b447edcac5f45f0b4dc6519bb650147 schema:name nlm_unique_id
71 schema:value 8003849
72 rdf:type schema:PropertyValue
73 N428ca519240b42948daf32128d698c5d schema:issueNumber 2
74 rdf:type schema:PublicationIssue
75 N44b0cb20ff0e492094cadb7200760d07 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Retrospective Studies
77 rdf:type schema:DefinedTerm
78 N4adb1a9ab147480a9641f068d1e8f2c9 schema:name doi
79 schema:value 10.1007/s00246-015-1278-2
80 rdf:type schema:PropertyValue
81 N57525419efaa4316b780cca453375e97 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Infant, Newborn
83 rdf:type schema:DefinedTerm
84 N5a4c5af2ebac42818f0c9e0257c642e3 rdf:first sg:person.01167214005.26
85 rdf:rest Nc42180b97abf4a03b84c74c7d1cc6e27
86 N5bfd2da748ea4479b57dba2f9180310e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Hypertension, Pulmonary
88 rdf:type schema:DefinedTerm
89 N5d9cd0fc6c174028b900dc6a5e073cd3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Lung
91 rdf:type schema:DefinedTerm
92 N669d5b9fa12f42e0bb1ae270aad871f4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Pyridazines
94 rdf:type schema:DefinedTerm
95 N7bedbeb554e1443eacc0c7fcfb0fe6ae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Echocardiography
97 rdf:type schema:DefinedTerm
98 N8a83458c03f84c5a86dcfb89f0de8371 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Pulmonary Artery
100 rdf:type schema:DefinedTerm
101 N9856b9778a494e23a083aee0a2f55985 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Infant
103 rdf:type schema:DefinedTerm
104 Na15ef977ac114eb78763da722d1f59d6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Antihypertensive Agents
106 rdf:type schema:DefinedTerm
107 Na2bf8183f35743878e3d3034a831e88b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Sulfonamides
109 rdf:type schema:DefinedTerm
110 Nb4ddeeda409f4e86b1b73b0bd638aaed schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Female
112 rdf:type schema:DefinedTerm
113 Nb50c60af0c2f4e048e70ac8a4098e679 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Child, Preschool
115 rdf:type schema:DefinedTerm
116 Nc197be0ec5bb4206bfe824c69df1eb03 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Child
118 rdf:type schema:DefinedTerm
119 Nc42180b97abf4a03b84c74c7d1cc6e27 rdf:first sg:person.01335364706.04
120 rdf:rest rdf:nil
121 Nca2bbb5a9ca541bda1f4dbc397eca934 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Abnormalities, Multiple
123 rdf:type schema:DefinedTerm
124 Nce8edd46ce50471388baf69697be4d29 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Pulmonary Atresia
126 rdf:type schema:DefinedTerm
127 Ncf26dba57694496ab44f4e97cb7df878 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name District of Columbia
129 rdf:type schema:DefinedTerm
130 Nd09cddcbc8304a498eb35bd3a81435c4 schema:name dimensions_id
131 schema:value pub.1027960295
132 rdf:type schema:PropertyValue
133 Nd559256b923c46b7b8d9c60797d564d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Tertiary Care Centers
135 rdf:type schema:DefinedTerm
136 Nd91043e806c94e2082a812b45690e09d schema:name Springer Nature - SN SciGraph project
137 rdf:type schema:Organization
138 Ne1a709498fa549f09a0ed4d3712f499b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Sildenafil Citrate
140 rdf:type schema:DefinedTerm
141 Ne1ad277e0e6745eaa411d6e511a8b677 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Adolescent
143 rdf:type schema:DefinedTerm
144 Ne5738c23e7054330b4beb87a5862b240 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Phenylpropionates
146 rdf:type schema:DefinedTerm
147 Ne77cc82e93144ab7a56f787bafff5f31 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Hospitals, Pediatric
149 rdf:type schema:DefinedTerm
150 Ne7e32e71d32047bfaf04cdd9899a6c1f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Catheterization
152 rdf:type schema:DefinedTerm
153 Ne925e005ab0445d8955b6eb8b9936686 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Young Adult
155 rdf:type schema:DefinedTerm
156 Neab702f8978746fbbe907558ca1bf130 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Hemodynamics
158 rdf:type schema:DefinedTerm
159 Nf414871eb01141c6ac5b312feb6237e2 schema:name readcube_id
160 schema:value 85316f006f2d53ad1f55b2544717a34d2bf0f08923d6eec1ae960235933634c3
161 rdf:type schema:PropertyValue
162 Nf75c0ce15e574d6aa24b9611d32227ae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Humans
164 rdf:type schema:DefinedTerm
165 Nf8f1e2749ff8402d9285317c18ad812a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Male
167 rdf:type schema:DefinedTerm
168 Nfd7f9318de0d4d56962d79e63bd7f49b schema:name pubmed_id
169 schema:value 26511384
170 rdf:type schema:PropertyValue
171 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
172 schema:name Medical and Health Sciences
173 rdf:type schema:DefinedTerm
174 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
175 schema:name Cardiorespiratory Medicine and Haematology
176 rdf:type schema:DefinedTerm
177 sg:journal.1091102 schema:issn 0172-0643
178 1432-1971
179 schema:name Pediatric Cardiology
180 rdf:type schema:Periodical
181 sg:person.01167214005.26 schema:affiliation https://www.grid.ac/institutes/grid.239560.b
182 schema:familyName Grant
183 schema:givenName Elena K.
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01167214005.26
185 rdf:type schema:Person
186 sg:person.01335364706.04 schema:affiliation https://www.grid.ac/institutes/grid.239560.b
187 schema:familyName Berger
188 schema:givenName John T.
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01335364706.04
190 rdf:type schema:Person
191 sg:pub.10.1007/s00246-012-0598-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026109233
192 https://doi.org/10.1007/s00246-012-0598-8
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1016/0735-1097(94)00364-v schema:sameAs https://app.dimensions.ai/details/publication/pub.1017446456
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1016/j.ijcard.2007.08.016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011119728
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1016/j.ijcard.2011.06.084 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046960818
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1016/j.ijcard.2012.03.021 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044464960
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1053/j.pcsu.2009.01.017 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011551210
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1097/pep.0b013e3182095e44 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038928599
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1161/circulationaha.109.192230 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018087707
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1161/circulationaha.113.005698 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028705550
209 rdf:type schema:CreativeWork
210 https://www.grid.ac/institutes/grid.239560.b schema:alternateName Children’s National Health System
211 schema:name Division of Cardiology, Children’s National Health System, 111 Michigan Avenue NW, 20010, Washington, DC, USA
212 Division of Critical Care Medicine, Children’s National Health System, 111 Michigan Avenue NW, 20010, Washington, DC, USA
213 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...